Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Clinical trial NCT06862856 · RECRUITING

Trial details

NCT number: NCT06862856
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen

Start date: 2025-05-20
Primary completion: 2026-01-16
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.